Navigation Links
EntreMed Reports Second Quarter 2012 Financial Results
Date:8/14/2012

ROCKVILLE, Md., Aug. 14, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and six-month periods ending June 30, 2012. 

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

EntreMed reported a net loss for the second quarter of 2012 of ($10.5 million), or ($0.56) per share. This compares with a net loss of ($1.7 million), or ($0.17) per share, for the same period last year.
For the first six months of 2012 the reported net loss was ($13.0 million), or ($0.86) per share as compared to ($4.3 million), or ($0.41) per share for 2011.  The 2012 net loss amounts included non-cash interest charges associated with our Strategic Financing totaling $9.2 million and $10.0 million for the three and six months ended June 30, 2012, respectively.  Excluding the non-cash interest, net loss for the second quarter and first six months of 2012 was ($1.3 million), or ($0.07) per share and ($3.0 million) or ($0.19) per share, respectively.

As of June 30, 2012, EntreMed had cash and cash equivalents of approximately $10.1 million.

Sara B. Capitelli, EntreMed's Vice President, Finance & Principal Accounting Officer, commented on the second quarter results, "Our second quarter 2012 financial results were in line with expectations.  Our research and development expenses for the second quarter decreased compared to the previous year as we completed enrollment of patients in the ENMD-2076 Phase 2 ovarian cancer study in 2011.  We anticipate third and fourth quarter operating expenses to increase as we execute on our clinical development plan in the US and China."

Ken Ren, PhD, EntreMed's Chief Executive Officer, further comme
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
2. EntreMed Reports First Quarter 2012 Financial Results
3. Nile Therapeutics Reports 2012 Second Quarter Financial Results
4. PDI Reports 2012 Second Quarter Financial Results
5. Neuland Labs Reports First Quarter Fiscal Year 2013 Financial Results
6. Patient Safety Technologies Reports Second Quarter 2012 Results
7. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
8. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
11. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
(Date:3/4/2015)... Pa. , March 4, 2015  Results of ... 100 Consecutive Cases Using MarginProbe for Intra-Operative Positive Margin ... poster session at the 32 nd Annual Miami ... study, conducted by Moshe Papa , MD, FACS, ... at Tel Aviv University, reports an analysis of MarginProbe,s ...
(Date:3/4/2015)... --  HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... is scheduled to present at the 2015 Barclays ... Tuesday, March 10, 2015.  The conference is being held ... Florida . A live ...
Breaking Medicine Technology:XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast 2
... Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... President and Chief Executive Officer, will provide an overview ... Capital 2012 Global Healthcare Conference on Tuesday, March 13, ... Miami Hotel in Miami, Florida.  The presentation will be ...
... Pharmacy Technician Certification Board (PTCB) Board of ... the organization,s new Executive Director and Chief Executive Officer. ... 2012, succeeding Interim Executive Director, William Schimmel, who is ... (Logo: http://photos.prnewswire.com/prnh/20120301/DC62761LOGO ) ...
Cached Medicine Technology:Colonel (Ret) Everett McAllister Named as New PTCB Executive Director and Chief Executive Officer 2
(Date:3/5/2015)... (PRWEB) March 05, 2015 Dr. Jim ... for Robotic Surgery at NewYork-Presbyterian/Weill Cornell Medical Center and ... at Weill Cornell Medical College. He assumed his new ... internationally renowned expert in the use of robotic and ... of the LeFrak Center, he will lead cutting-edge clinical ...
(Date:3/5/2015)... Hope For The Warriors® is excited to ... be held at Beretta Shooting Grounds (Dover Furnace) in Dover ... the event will benefit Hope For The Warriors®, a national ... family unit, and restoring hope for our service members and ... heroes through a day of clay shooting at Beretta Shooting ...
(Date:3/5/2015)... March 05, 2015 Developers and plugin ... have announced a new transition pack entitled TranSlice Wipe ... split screen transitions with ease while maintaining a professional ... “TranSlice Wipe is a time saver with transitions our ... Studios brings back split screen transitions with a new ...
(Date:3/5/2015)... 05, 2015 Aureus Medical Group (web: ... tenens and direct hire physician jobs, has announced that ... Academy of Family Physicians 67th Annual Meeting & Scientific ... Vista, Nebraska. , The Annual Meeting & Scientific ... networking opportunities, and an exhibition of products and services. ...
(Date:3/5/2015)... 05, 2015 Anthony Grace, ... Psychiatry and Psychology Department of Neuroscience, University of ... upcoming BioConference Live Neuroscience, a two-day online event ... webcast , titled “Dopamine System Dysregulation in ... for Thursday, March 18, from 9 a.m. to ...
Breaking Medicine News(10 mins):Health News:Robotic Surgery Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Robotic Surgery Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Robotic Surgery Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2Health News:Pixel Film Studios Released TranSlice Wipe Exclusively for Final Cut Pro X Editors 2Health News:Healthcare Staffing Agency, Aureus Medical Group, to Exhibit at the Nebraska Academy of Family Physicians Annual Meeting & Scientific Assembly 2Health News:Anthony Grace, MD, PhD, to Deliver Keynote at BioConference Live Neuroscience 2015 2Health News:Anthony Grace, MD, PhD, to Deliver Keynote at BioConference Live Neuroscience 2015 3
... obsession of MP3 players that blare out music loudly is at ... generation.// Researchers from the Deafness Research, UK, found that 14 to ... 28 hours per week. ,Over a third of the ... sure sign of damage to hearing, after listening to loud music. ...
... General of Health Debbie Chin herbal products imported ... in erectile// dysfunction and weight loss prescription medicines. ... remedies that contained drugs which could be fatal ... dysfunction drug which could also interfere with some ...
... risen since the government sang from the "one for Mum, ... and began paying out 3,000 Australian// dollars ($2,100) for every ... Treasurer Peter Costello wants to hear the pitter-patter of more ... in order to reverse the declining fertility rate that is ...
... could cause a change in the role of district nurses.// ... roles of community health professionals such as health visitors and ... about 9,000 nurses across Scotland. ,These were the ... major review of the community health sector for the health ...
... Medical Council of India (MCI) on a PIL seeking a ban ... Arijit Pasayat and Justice Lokeshwar Singh Panta asked the Centre and ... Treatment, within six weeks. It further gave four weeks to the ... MCI., ,The petitioner raised the issue of the death of ...
... Ontario from Lebanon will not have to wait for access ... said that it will waive the mandatory three-month waiting period ... ,According to the Health Minister George Smitherman the evacuees have ... access to the "health care they need when they need ...
Cached Medicine News:Health News:Australia's Baby Bonus Plan has Increased the Birth Rate 2
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 230 V, 50 Hz gel drying oven....
... The PRO6000 power supply is ... power supply product offering. It ... and genomic electrophoresis. This product ... proteomic applications such as microAmp ...
... Operating as a constant voltage power supply, the ... knob and hilo range switch control the output, ... to 250 volts. One, two-position switch toggles the ... output current. The 105 is equipped with an ...
... The 250-90 low voltage electrophoresis power supply ... 500 milliamps and 125 watts. This product operates ... continuously variable output. The 250-90 automatically crosses over ... when a preset limit is reached. ...
Medicine Products: